Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The American Brain Tumor Association’s BT5K Run & Walk is a family-friendly fundraiser to support brain tumor research and patient services.
The problem with this attitude is that if anything goes—if everything is permissible—then nothing matters.
The National Brain Tumor Society on research, progress and the eighth annual Head to the Hill
All 12 treated children with NTKR, ROS1 or ALK gene abnormalities showed partial or compete tumor shrinkage.
“It is unthinkable that a doctor could tell you that there is nothing that can be done for your child,” says Kathryn R. Taylor, PhD.
An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.
The vaccine, based on an individual’s own tumor cells, improved survival time and proved safe in an early-stage trial.
Join us Sunday, April 28, 2019, to raise money, awareness, and connectedness with and for the National Brain Tumor Society!
While her response is not average, doctors say it represents a step forward for people with diffuse midline gliomas, a rare cancer.
Angela J. Waanders, MD, MPH, is tackling pediatric brain cancer.
Cancer organizations and the Food and Drug Administration want to broaden eligibility criteria for cancer clinical trials.
A new breed of patient advocate is reshaping the future of cancer research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.